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Induction of the NF-B Cascade
by Recruitment of the Scaffold Molecule
NEMO to the T Cell Receptor
whose absence leads to a complete lack of NF-B acti-
vation. The IKK complex is responsible for the phosphor-
ylation of the IB inhibitory subunits, which are rapidly
degraded by the proteasome after polyubiquitination.
The degradation of IBs results in the release of NF-
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been implicated in IKK activation by CD3/CD28. Other3 Unite´ d’Immunologie Mole´culaire
studies have found that three new proteins (CARMA1,CNRS URA 1961
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signaling pathways that lead to activation of NF-B (Li75724 Paris Cedex 15
and Verma, 2002). While some of the players that lead toFrance
NF-B activation in response to TCR/CD28 stimulation
have been identified, the molecular mechanism of IKK
activation is poorly understood. In the present study weSummary
show that T cell activation induces recruitment of the
IKK complex to the immunological synapse. This findingThe mechanism by which TCR signaling activates NF-
is consistent with the idea that the binding of IKK toB is poorly understood. We demonstrate here that the
components of the receptor complex constitutes a criti-IKK kinase complex is recruited to the immunological
cal step in the activation of the signalosome. To testsynapse and can be coprecipitated with the TCR after
this hypothesis, we fused NEMO to the tandemly re-T cell activation. Using ZAP-70-deficient T cells ex-
peated SH2 domains of ZAP-70 (SNEMO) in order topressing a hybrid molecule between the SH2 domain
promote recruitment of the signalosome to the TCR afterof ZAP-70 and NEMO/IKK, we showed that targeting
its ligation. We used a Syk/ZAP-70 deficient T cell lineNEMO to the immunological synapse, and more spe-
(Williams et al., 1998) that displays severe defects incifically its 120 N-terminal amino acids, was sufficient
TCR signaling including NF-B activation, which are cor-to selectively restore NF-B activation in response to
rected by reintroduction of wild-type ZAP-70. Comple-TCR ligation. Finally, we demonstrated that targeting
mentation of these cells with SNEMO specifically recon-of NEMO to the membrane of T cells was sufficient to
stitutes TCR-induced recruitment of this molecule to theinduce constitutive NF-B activation. This study shows
immunological synapse (and to the TCR complex) andthat the localization of NEMO to the immunological
NF-B activation. In addition, we demonstrated that thesynapse is important for TCR-induced NF-B activa-
N-terminal 120 amino acids of NEMO, the minimal regiontion and offers a powerful system to dissect the NF-
required for interaction with the kinase subunits, were
B cascade in T cells.
sufficient to restore activation when fused to the tandem
SH2 domains of ZAP-70. Finally, we demonstrated thatIntroduction
attachment of a membrane-targeting sequence to NEMO
was sufficient to induce constitutive NF-B activation.
Upon TCR ligation, the Src family PTKs, Lck and Fyn,
phosphorylate the immuno-receptor-based tyrosine ac- Results
tivation motifs (ITAMs) found in the cytoplasmic do-
mains of the TCR and CD3 subunits (Hermiston et al., Recruitment of NEMO to the TCR in Response
2002). A critical function of the phosphorylated ITAMs to CD3 and CD28 Costimulation
is to bind the tandem Src homology 2 (SH2) domains of Mobility shift assays have demonstrated that stimulation
Syk family PTKs, including ZAP-70 (Hermiston et al., by both the CD3 and CD28 pathways is required to
2002). Once ZAP-70 is activated, Lck and ZAP-70 act activate NF-B in Jurkat (Herndon et al., 2001; data not
in concert to phosphorylate downstream substrates shown). To test the possibility that such a response
leading to the activation of multiple transcription factors, might be due to recruitment of the IKK complex to the
including NFAT, AP1, and NF-B. These factors ulti- TCR, Jurkat T cells were stimulated with mAbs to CD3
mately control the transcription of cytokines and T cell and CD28, and immunoprecipitation experiments were
proliferation. CD28 synergizes with the TCR in activating performed (Figure 1A). Endogenous NEMO was coim-
the IKK complex, a central element of the NF-B cas- munoprecipitated with the TCR chain after 5 and 15
cade. This complex is composed of three subunits: min of stimulation (lanes 2 and 3), and this interaction
IKK, IKK, and NEMO/IKK (Karin and Ben-Neriah, was no longer detectable after 30 min of stimulation.
2000). Both IKK and IKK are catalytic kinase subunits
while NEMO/IKK is a structural and regulatory subunit, NEMO Is Recruited to the Immunological Synapse
after T Cell Activation
Upon antigen recognition, TCRs, coreceptors, and sig-* Correspondence: rweil@pasteur.fr
4 These authors contributed equally to this work. naling molecules polarize to the T cell-APC contact site,
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Figure 1. T Cell Activation Induces Recruitment of the IKK Complex to the Immunological Synapse
(A) The NEMO/IKK complex is recruited to the CD3 chain upon CD3/CD28 costimulation. Jurkat cells were stimulated for the indicated
periods of time, lysed, and immunoprecipitated with an Ab raised against CD3 chain. The Western blots were probed with anti-NEMO Ab.
(B) NEMO is recruited to the immunological synapse. Jurkat T cells were incubated with APCs (Raji B cells) and prepulsed with medium alone
(a) or with 5 g/ml of SEE superantigen (b–d). At different times, cells were fixed and TCR and NEMO localized by immunofluorescence and
confocal microscopy, using anti-TCR and anti-NEMO Abs, as described in the Experimental Procedures. Representative T cell-APC conjugates
are shown. The pictures represent xy projections of three medial optical sections (middle three panels), or xz projections of the whole stack
of optical sections corresponding to T cell-APC contact zone (far right panels). Arrows show the positions of TCR and NEMO central clusters
and the accumulation of NEMO in membrane extensions in contact with the APC. Control (nonstimulated) cells at 30 and 45 min gave similar
patterns of localization of NEMO and TCR (data not shown) to those observed at 15 min (a). Bar  5 m.
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termed the immunological synapse, and segregate into identified using anti-NEMO (Figure 2A, top panel) or anti-
NRP (bottom panel) antisera. Three cell lines expressingsupramolecular activation clusters. The “mature” immu-
SNEMO or SNRP at levels similar to endogenous NEMOnological synapse observed between T cells and anti-
and NRP were retained for further studies, and all ex-gen-presenting B cells is formed by a central cluster of
pressed unaltered levels of TCR, CD3, CD45, and CD28TCRs, coreceptors, and signal transduction molecules
at the cell surface (data not shown).(i.e. Lck, ZAP-70, PKC, etc.), surrounded by a more
To ensure that the SNEMO construct was functional,peripheral accumulation of adhesion receptors and cy-
SVT-2C NEMO-deficient Jurkat cells (Harhaj et al., 2000)toskeleton-associated molecules (i.e., LFA-1 and talin,
were stably transfected and individual cell lines express-respectively) (Grakaoui et al., 1999; Monks et al., 1998).
ing SNEMO were generated. As expected, stable ex-It has been previously shown that the IKKs localized
pression of NEMO in SVT-2C cells induced high levelsto the membrane after T cell activation (Khoshnan et al.,
of NF-B DNA binding activity following PMA/ionomycin2000); however, the activation procedure used by these
stimulation (Figure 2B, lane 4). SNEMO-expressing cellsinvestigators (using soluble antibodies) did not allow
also gave rise to NF-B activity after PMA/ionomycinthem to study the T cell-APC contact area. To investigate
treatment (lane 6). Unfortunately, we were unable towhether NEMO could be recruited to TCR signaling com-
assay TCR stimulation in these cells as they lack ex-plexes at the immunological synapse, we carried out
pression of the TCR, CD3, and CD45 (data not shown).immunolocalization studies. To this end, Jurkat cells
Thus, SNEMO is able to complement a NEMO-defectivewere stimulated with bacterial superantigen-pulsed B
cell line.cells under conditions that lead to TCR clustering at the
To directly assess whether SNEMO or SNRP couldT cell-APC contact zone (Roumier et al., 2001). Then,
bind to the ITAMs, we incubated in vitro translatedTCR and NEMO were localized by confocal microscopy.
SNEMO and SNRP with a phosphorylated ITAM peptideAs shown in Figure 1B, at 15 min of activation, NEMO
(Figure 2C). In the absence of competitor peptide,accumulated in the T cell-APC contact zone in both the
SNEMO and SNRP could bind to the ITAM peptide (lanescentral and the peripheral zones (Figure 1Bb, arrows).
4 and 7), while NEMO could not (lane 1). Moreover, theThe central cluster of NEMO colocalized with the TCR
2pY-ITAM but not the pY-ITAM inhibited the interaction
cluster in that area. Moreover, NEMO also strongly accu-
between SNEMO or SNRP and the ITAM peptide (com-
mulated in membrane extensions that enlarge the area
pare lanes 6 and 9 with lanes 5 and 8). It is interesting
of contact with the APC at this time of activation (Rou-
to note that SNRP shows a higher affinity for the 2pY-
mier et al., 2001). In contrast, control cells incubated in ITAM peptide, possibly due to a problem of steric hin-
the absence of stimulus did not display any accumula- drance by the NRP versus NEMO part of the molecule.
tion of NEMO at the contact site (Figure 1Ba). At 30 min In order to evaluate the interaction between SNEMO or
of activation, the T cell membrane extensions were less SNRP and the ITAMs in vivo, ZAP-70-deficient p116
prominent and the accumulation of NEMO much weaker. clones expressing either SNEMO or SNRP, were stimu-
Moreover, the accumulation of NEMO in the TCR cluster- lated with an anti-TCR mAb and the ability of SNEMO
ing area was very weak or undetectable (Figure 1Bc, and SNRP to interact with the ITAMs was examined by
arrows). Over 30 min of activation, most T cell-APC con- immunoblotting of anti-TCR immunoprecipitates with
jugates displayed no clear accumulation of NEMO in the anti-NEMO or anti-NRP antibodies (Figure 2D). This experi-
contact zone, although the TCR cluster was still quite ment demonstrated that SNEMO and SNRP are recruited
strong (Figure 1Bd, arrows). Altogether these data show to the TCR/CD3 complex following TCR stimulation (lanes
that, after T activation, NEMO is transiently recruited to 2–6 and 8–10). However while the /SNEMO interaction is
the immunological synapse and colocalizes with the lost after 30 min, the /NRP interaction is very stable,
TCR cluster. possibly for a reason similar to that responsible for the
difference observed in Figure 2C. Thus, these two chime-
ric molecules can efficiently bind to 2pY-ITAM peptide
SNEMO Can Complement NEMO-Deficient Cells and interact with the  chain of the TCR.
and Be Recruited to the ITAMs
The recruitment of the IKK complex to the TCR appears SNEMO Is Recruited to the Immunological Synapse
to be an important step in TCR-mediated NF-B activa- after T Cell Activation
tion. To gain support of this notion, we fused NEMO to Consistent with the coimmunoprecipitation of SNEMO
the tandemly repeated SH2 domains of ZAP-70 with the CD3 chain, we observed in activated SNEMO-
(SNEMO) in order to promote recruitment of the signalo- expressing cells an accumulation of SNEMO at the T
some to the TCR after its ligation. NRP was also fused cell-APC contact zone, colocalized with the TCR clus-
to the SH2 domains of ZAP-70 (SNRP) and used as a tered in that area (Figure 2Eb). As expected, in the ab-
negative control since NRP is unable to activate NF-B sence of superantigen, no accumulation of SNEMO was
(Schwamborn et al., 2000). We expressed these chime- observed (Figure 2Ea), indicating that clustering of
ras in a Syk/ZAP-70-deficient cell line (p116) derived SNEMO required TCR-mediated signaling. In contrast
from the Jurkat E6 T cell line (Williams et al., 1998) that to NEMO in Jurkat cells, SNEMO transfected p116 cells
displays severe defects in TCR signaling including NF- did not accumulate SNEMO in membrane extensions at
B activation. We confirmed (see Figure 4A) that p116 the APC contact site. This is probably due to the fact
cells were defective in NF-B activation in addition to that direct targeting of NEMO to the TCR precludes its
other signaling defects. localization in the membrane extensions where the TCR
is not located. Besides, p116 cells have been shown toIndividual p116 transfectants were generated and
Immunity
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Figure 2. Characterization of the SNEMO Chimeric Construct
(A) SNEMO and SNRP expression in p116-derived subclones. Detergent-soluble proteins from wild-type p116 cells or the indicated p116
subclones were immunoprecipitated with anti-NEMO (top panel) or anti-NRP (bottom panel), separated by SDS-PAGE, and immunoblotted
with anti-NEMO or anti-NRP specific Abs.
(B) Complementation of NEMO-deficient cell line by SNEMO. Bandshift assay of nuclear extracts from SVT-2C cells either nontransfected
(NT, lanes 1 and 2), or stably transfected with NEMO (lanes 3 and 4) or SNEMO (clone 13, lanes 5 and 6). Cells were either untreated or
stimulated for 30 min with PMA and ionomycin as indicated. We noticed that a fast migrating nonspecific band (lanes 4–6) was induced by
G418 treatment.
(C) SNEMO and SNRP bind to the ITAMs. Association of SNEMO and SNRP with a 2pY-ITAM peptide. Binding of 35S-in vitro translated NEMO,
SNEMO, and SNRP (1 l of the translation products) to diphosphorylated biotinylated ITAM peptides in the absence (	) or presence of an
excess concentration of mono- (P) or diphosphorylated (PP) ITAM peptides. One microliter of the reticulocyte translation products was run
in parallel (lanes 10–12).
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be unable to form this type of membrane protrusions kinase activity, endogenous NEMO and SNEMO were
immunoprecipitated from resting or TCR-induced cells(data not shown). These data show that in intact cells
SNEMO is recruited to signaling complexes that are (Figure 3D, top panel). The immune complexes were
assayed for phosphorylation of a glutathione S-trans-formed at the immunological synapse.
ferase (GST) fusion protein containing the amino-termi-
nal region of IB in the wild-type context (wt) or mu-SNEMO Restores TCR-Dependent NF-B Activation
tated on its two phosphorylation sites (2A). As expected,in p116 Cells
endogenous NEMO from untransfected p116 cells wasTo evaluate the ability of SNEMO to correct the NF-B
not found to be associated with an activated kinasedefect observed in p116 cells, three different clones
complex following stimulation for 10 min with anti-TCRexpressing either SNEMO or SNRP were tested for their
mAb (lanes 1–4). In contrast, in cells stably transfectedability to induce NF-B binding activity (Figure 3A, top
with SNEMO, an inducible kinase activity associatedpanel). Mobility shift experiments demonstrated that the
with NEMO immunoprecipitates could be observed (lanethree cell lines expressing SNEMO could induce NF-B
8). Using an antibody raised against SH2 domains ofnuclear translocation in response to TCR stimulation
ZAP-70, we have confirmed that this kinase activity was(compare lanes 4, 6, and 8 with lanes 3, 5, and 7). This
associated with SNEMO (lanes 13–16) but not with SNRPeffect was specific since three independent cell lines
(lanes 9–12). Next, we examined the kinetics of appear-expressing SNRP failed to activate NF-B (lanes 9–14),
ance of the kinase activity associated with SNEMO fol-and as expected, the parental p116 cell line was also
lowing TCR or PMA/ionomycin induction and found itrefractory to TCR stimulation (lanes 1 and 2). In a time
to be fast, reaching a maximum after 2 min of TCRcourse analysis (Figure 3A, bottom panel), cells express-
activation (Figure 3D, bottom panel, lanes 1–6), withing SNEMO (lanes 7–12) demonstrated a TCR-induced
more progressive induction after PMA/ionomycin treat-NF-B nuclear translocation after 5 min of stimulation,
ment (lanes 7–11).while no NF-B DNA binding activity could be observed
Finally, the ability of SNEMO to activate NF-B inin nontransfected p116 cells or cells stably transfected
response to TCR engagement was confirmed by tran-with SNRP (lanes 1–6 and lanes 13–18). Thus, the
scriptional activation of a NF-B-dependent luciferaseSNEMO chimeric protein can induce a rapid NF-B nu-
reporter gene (Figure 3E).clear translocation in response to TCR ligation.
A key step that leads to NF-B activation in response
to many extracellular stimuli is the phosphorylation of SNEMO Specifically Induces NF-B Activation
in p116 CellsIB followed by its degradation. Therefore, we deter-
mined whether TCR stimulation could induce degrada- Coengagement of the TCR and CD28 leads to complete
and productive activation of T cells. This combined stim-tion of IB in p116 cells stably transfected with SNEMO,
and, if so, whether it was dependent on its phosphoryla- ulation leads to activation of NFAT through calcium mo-
bilization and activation of the phosphatase calcineurin,tion. In Figure 3B, top panel, nontransfected p116 cells
(lanes 1–5) or cells stably transfected with SNEMO (lanes and to activation of AP1 and NF-B. To our knowledge,
there is no available system allowing separation of6–10) or SNRP (lanes 11–15) were treated with anti-
TCR mAb, and the degradation of IB was analyzed NF-B induction from other signaling pathways. To eval-
uate whether SNEMO selectively reconstitutes NF-Bby immunoblotting using anti-IB antibody. Degrada-
tion of IB in p116 cells stably transfected with SNEMO activation in p116 cells, transient transfection experi-
ments were performed using Ig-cona-luc or NFAT-lucwas noticeable between 5 and 60 min of TCR stimulation
(lanes 7–10), whereas no degradation was observed in as a readout for transcriptional activation. In p116 cells,
a weak stimulation of NFAT activity (1.6-fold activationp116 cells (lanes 1–5) or SNRP-expressing cells (lanes
11–15). Consistently, immunoblotting analysis with anti- compared to nonstimulated cells) could be observed
following CD3 
 CD28 costimulation (Figure 4A, leftphospho-IB antibody showed that in the presence of
ALLN (a proteasome inhibitor), TCR induction was able panel), which was increased about 7-fold in cells recon-
stituted with wt ZAP-70. Importantly, no increase wasto induce endogenous IB phosphorylation in SNEMO-
expressing cells (bottom panel, compare lanes 4 and 2). observed in cells expressing SNEMO, indicating that
SNEMO does not allow NFAT activation. On the otherTo confirm that SNEMO is, like NEMO, an integral
part of the IB kinase complex, we used an anti-IKK1 hand, SNEMO expression allowed NF-B activation
after CD3 stimulation (5-fold activation compared toantibody to immunoprecipitate the IKK complex (Figure
3C). The results revealed that, independently of TCR nonstimulated cells), and this was further increased fol-
lowing CD3 
 CD28 costimulation (right panel).stimulation, endogenous NEMO and SNEMO were asso-
ciated with IKK1 (lanes 1–6). In order to investigate We then analyzed the accumulation of phosphotyro-
sine-containing proteins in stable ZAP-70, SNEMO, andwhether SNEMO is associated with a TCR-inducible IB
(D) SNEMO and SNRP are recruited to CD3 chain after TCR ligation. The indicated p116 subclones were stimulated for the indicated times
with anti-TCR mAb. The cells were lysed, and CD3 immunoprecipitates were immunoblotted with anti-NRP or anti-NEMO Abs.
(E) SNEMO is recruited to the immunological synapse. P116 cells transfected with SNEMO were incubated with APCs (Raji B cells) and
prepulsed with medium alone (a) or with 5 g/ml of SEE superantigen (b). At different times, cells were fixed and TCR and SNEMO localized
by immunofluorescence and confocal microscopy, using anti-TCR-CD3 and anti-HA tag Abs, as described in the Experimental Procedures.
Arrows show the position of TCR and NEMO in central clusters. Pictures show a medial optical section of representative T cell-APC conjugates.
Bar  5 m.
Immunity
18
Figure 3. NF-B Activation in p116 Cells Stably Transfected with SNEMO
(A) SNEMO induces NF-B nuclear translocation in response to TCR ligation in p116 cells. (Top panel) Nuclear extracts were collected from
nontransfected p116 cells (NT) or different subclones expressing SNEMO (clones 5, 17, and 18) or SNRP (clones 2, 18, and 22) that were left
untreated (	) or stimulated for 60 min with anti-TCR mAb (
) and assayed by bandshift. The NF-B retarded band is indicated by an arrow.
(Bottom panel) Time course of TCR-induced nuclear translocation of NF-B. The indicated p116 subclones were stimulated for the indicated
periods of time with anti-TCR mAb. Then, nuclear extracts were collected, and bandshift assays were performed.
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Figure 4. T Cell-Specific Activation of NF-B
(A) SNEMO selectively reconstitutes the NF-B pathway in p116 cells. (Left panel) NFAT activation in stably transfected p116 cells. The cells
were transiently transfected with the pNFAT-luc reporter plasmid. Cells were stimulated as indicated, and luciferase activities were determined
and plotted as arbitrary units. The data shown are the means of two independent experiments. (Right panel) NF-B activation in stably
transfected p116 cells. P116 subclones were transiently transfected with Ig-cona-luc, cells were stimulated, and luciferase activities determined
as described above.
(B) Protein tyrosine phosphorylation in TCR-stimulated p116 cells expressing SNEMO or SNRP. Representative cell lines expressing wild-
type ZAP-70, SNEMO, or SNRP were stimulated for the indicated periods of time with anti-TCR antibodies. Changes in intracellular protein
tyrosine phosphorylation were assayed by immunoblotting of total cell lysates with anti-phosphotyrosine antibody. The position of MWM is
indicated on the right.
(B) Phosphorylation and degradation of IB in p116 cells expressing SNEMO. (Top panel) P116 cells (NT) or subclones expressing SNEMO
or SNRP were stimulated for the indicated periods of time with an anti-TCR mAb, after which cells were lysed and the degradation of IB
was determined by immunoblot analysis using anti-IB antiserum. (Bottom panel) Protein extracts from uninduced or TCR-stimulated p116
and p116 SNEMO cells (clone 17) were separated by SDS-PAGE and immunoblotted with a phospho-IB-specific antibody. The position of
phosphorylated IB is indicated on the right. NS, nonspecific band.
(C) SNEMO is part of the IB kinase complex. P116 and p116 subclones expressing SNEMO were left untreated or were stimulated with an
anti-TCR mAb for 30 min. Then, IKK complexes were immunoprecipitated and analyzed by anti-NEMO immunoblotting for the presence of
SNEMO and endogenous NEMO.
(D) SNEMO is associated with an inducible IB kinase activity. (Top panel) P116 cells and subclones expressing SNEMO or SNRP as indicated
were either nonstimulated (	) or stimulated (
) for 10 min with anti-TCR mAb. After lysis, NEMO, SNRP, and SNEMO proteins were recovered
by immunoprecipitation with either NEMO (lanes 1–8) or anti-(SH2)2 (lanes 9–16) Abs. Kinase activity was assayed by immune complex
reactions in the presence of (-32P)ATP and 1 g of GST-IB 1-66 wild-type (referred as wt) or GST-IB A32A36 (2A) as substrate. The
positions of the phosphorylated substrates are indicated on the right. (Bottom panel) P116 cells expressing SNEMO (clone 17) were incubated
either with anti-TCR mAb or with PMA and ionomycin for the indicated periods of time. Whole-cell lysates were immunoprecipitated with HA
antiserum and subjected to a kinase assay using GST-IB 1-66 wild-type as substrate.
(E) Activation of an Ig-cona-luc reporter gene in p116 cells expressing SNEMO. Nontransfected (NT) or p116 cells stably transfected with
SNEMO or SNRP were transfected with Ig-cona-luc. Twelve hours after transfection, cells were left untreated or stimulated for 6 hr with anti-
CD3 mAb, after which luciferase activities were measured and plotted as arbitrary units.
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Figure 5. Activation of NK-B in p116 Cells Expressing Different Truncated Variants of SNEMO
(A) Stable expression of truncated variants of SNEMO in p116 cells. (Top panel) Schematic illustration of SNEMO constructs. Boxes represent
the two coiled coil regions (CC1, CC2), the leucine zipper domain (LZ) and the zing finger (ZF). (Bottom panel) Immunoblotting of whole-cell
extracts from SDN97-, SDC255-, SDC299-, and SDC120-expressing cells with anti-HA mAb.
(B) Structural requirement of SNEMO for binding to the IKK kinase complex. (Left panel) Representative cell lines expressing SNEMO, SDN97,
SDC255, and SDC299 were lysed and subjected to anti-IKK1 immunoprecipitation followed by anti-NEMO immunoblotting. The position of
IKK Recruitment to TCR or Membrane Activates NF-B
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SNRP transfectants stimulated with anti-TCR antibodies Extracts of p116 nontransfected cells (Figure 5D,
lanes 1 and 2), stably transfected with SNEMO (lanes 3(Figure 4B). This experiment showed that in contrast
to the cells reconstituted with ZAP-70 (lanes 1–5), no and 4), SDN97 (lanes 5 and 6), SDC120 (lanes 7 and 8),
SDC255 (lanes 9 and 10), or SDC299 (lanes 11 and 12)increase could be observed in cells expressing SNRP
or SNEMO (lanes 6–15). In conclusion, complementation were immunoprecipitated with HA mAb following mock
or TCR activation. The catalytic activities of the immuno-of p116 cells with SNEMO specifically reconstitutes
NF-B activation. precipitates were determined by immune complex ki-
nase assay with the amino-terminal part of IB fused
to GST as a substrate. As shown previously (see FigureDeletion Mapping of the SNEMO Domain Sufficient
to Restore NF-B Activation 3D), SNEMO was associated with an inducible kinase
activity (compare lanes 3 and 4). As expected, we couldTo determine the role of the individual domains of
SNEMO in reconstituted NF-B signaling, we used a not observe any kinase activity associated with SDN97
(lanes 5 and 6). However, the kinase activities associatedseries of N- (SDN97) and C-terminal (SDC120, SDC255,
SDC299) truncation mutants of SNEMO (Figure 5A, top with SDC255 and SDC299 (compare lanes 3 and 4 to
lanes 9–12) were similar to that of full-lengh SNEMO. Inpanel). These constructs were expressed in the p116
cell line, detected with anti-HA antibody, and for each, the case of SDC120 (lanes 7 and 8), the weak (but still
inducible) kinase activity correlated with the reducedthree individual transformants were retained for further
studies (Figure 5A, bottom panel). Immunoblot analysis association between SDC120 and IKK kinases (Figure
5B, right panel).with anti-NEMO antibody revealed that the mutant pro-
teins were expressed at levels similar to the endogenous In accordance with their ability to induce NF-B nu-
clear translocation, SDC299, SDC255, and SDC120 wereNEMO protein (data not shown). The N-terminal domain
of NEMO has been shown to interact with IB kinases able to activate a NF-B-dependent luciferase reporter
gene while SDN97 was not (Figure 5E, right and left(May et al., 2000). Indeed, deletion of the 97 N-terminal
amino acids of SNEMO prevented the interaction with panels).
endogenous IKK1 (Figure 5B, left panel, lane 3) and
NF-B nuclear translocation in response to TCR stimula- Constitutive Activation of NF-B Induced
by the Expression of Myristylated Forms of NEMOtion (Figure 5C, top panel, lanes 3–8). As expected, dele-
tion of the 120 (DC299) or 164 C-terminal amino acids Based on the data presented above, we propose a
model whereby the signalosome is activated through itsof SNEMO (DC255) was not sufficient to disrupt the
interaction of SNEMO with IKK1 (Figure 5B, compare recruitment to the TCR. To directly determine whether
recruitment of NEMO to the membrane is sufficient tolanes 4, 5, and 2) and consequently could restore NF-
B nuclear translocation (Figure 5C, top panel, lanes activate NF-B, we generated a modified construct
which consists of the N-terminal membrane-targeting9–20). To determine the level of interaction of SNEMO
deleted of its 299 C-terminal amino acids (SDC120) with sequence of Lck (aa 1–12) attached to the NH2 terminus
of NEMO (MN). This sequence is able to target a proteinthe IKK complex, lysates from cells expressing SDC120
were immunoprecipitated with an anti-HA antibody and into the GEMs (glycosphingolipid-enriched membranes)
(Resh, 1999). We also generated a fusion construct be-then subjected to an anti-IKK1 immunoblotting (Figure
5B, right panel). This experiment demonstrated that tween the N-terminal sequence of Src (aa 1–14) and
NEMO (MSN) which can address NEMO to the mem-compared to SNEMO (lane 2), SDC120 interacted poorly
with IKK1 (lane 3). However, this interaction was also brane but not into the GEMs (Resh, 1999). In order to
determine if these constructs are functional, we tran-sufficient to restore the activation (Figure 5C, bottom
panel, lanes 7–10). Immunoblotting of total lysates with siently transfected these plasmids into a NEMO-defi-
cient cell line and restored NF-B activation (data notanti-IKK1 or HA showed that IKK1 is equally well ex-
pressed in the cell lines used for this experiment (Figure shown). Individual clones expressing MN or MSN were
generated in the NEMO-deficient-SVT-2C cells (Figure5B, middle, lanes 1–3) and that the levels of expression
of DC120 and SNEMO are identical (bottom, compare 6A). For each stable transfectant, three cell lines ex-
pressing MN and MSN were retained for our studieslanes 2 and 3).
MWM is indicated on the right, and the migration of SNEMO, SDC299, SDC255, and NEMO is indicated on the left. (Right panel) Nontransfected
p116 cells or subclones expressing SNEMO or SDC120 were lysed and subjected to anti-HA immunoprecipitation followed by anti-IKK1
immunoblotting. The middle and the bottom parts of the figure show immunoblotting of whole-cell extracts with anti-IKK1 or anti-HA mAbs.
The migration of IKK1, SNEMO, and SDC120 is indicated on the left.
(C) Bandshift assay of nuclear extracts from p116 cells expressing different truncated variants of SNEMO. (Top panel) P116 cells stably
transfected with SNEMO, SDN97, SDC255, or SDC299 were either left untreated (	) or treated for 30 min with anti-TCR mAb (
). Nuclear
extracts were prepared, and bandshift assays were performed as indicated in the Experimental Procedures. (Bottom panel) Nontransfected
p116 cells or subclones expressing SNEMO or SDC120 were stimulated and lysed as described above, and bandshift assays were performed.
(D) Kinase activity associated with different truncated variants of SNEMO in p116 cells. Representative cell lines expressing SNEMO, SDN97,
SDC120, SDC255, and SDC299 were incubated with anti-TCR for 10 min. Whole-cell lysates were immunoprecipitated with HA mAb and
subjected to a kinase assay using GST-IB 1-66 as substrate.
(E) Activation of NF-B in p116 cells expressing different truncated variants of SNEMO. (Left panel) Nontransfected p116 cells (NT) or cells
stably transfected with SNEMO, SNRP, or expressing increasing amounts of SDN97, SDC255, or SDC299 were transiently transfected with
the Ig-cona-Luc reporter plasmid. After 12 hr, cells were stimulated with medium only (control) or anti-CD3 mAb. Luciferase activities were
plotted as arbitrary units. (Right panel) Nontransfected p116 cells (NT) or cells stably transfected with SNEMO or SDC120 (two different clones)
were transiently transfected with Ig-cona-luc, stimulated as described above, and the luciferase activities were determined.
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Figure 6. Membrane Targeting of NEMO Induces NF-B Activation
(A) Stable expression of MN and MSN in SVT-2C cells. Immunoblotting of whole-cell extracts from the indicated subclones with anti-NEMO Ab.
(B) MN and NSN localize at the cell membrane in NEMO deficient T cells. P116 cells were transfected with plasmids expressing NEMO (a),
MN (b), or MSN (c). The cellular distribution of these proteins was visualized by confocal microscopy using anti-NEMO Ab as described in
the Experimental Procedures. Bar  5 m.
(C) Constitutive nuclear translocation of NF-B in MN- and MSN-expressing SVT-2C cells. Bandshift assay of nuclear extracts from SVT-2C
(lanes 1 and 6) or subclones of these cells expressing MN, MSN, or NEMO (N) as indicated.
(D) Constitutive activation of an NF-B reporter gene in MN- or MSN-expressing SVT-2C cells. (Left panel) Nontransfected SVT-2C cells (NT),
cells stably transfected with NEMO or with MN (clones 5, 19, and 20) were transiently transfected with Ig-cona-luc or with cona-luc.
Experiments have been repeated three times, and results are expressed as average fold induction relative to cona-luciferase transfected
cells. (Right panel) Nontransfected SVT-2C cells or subclones of cells stably transfected with MSN (clones 2, 4, and 5) were transiently
transfected with Ig-cona-luc or with cona-luc. Experiments have been repeated three times, and results are expressed as average fold
induction relative to cona-luc transfected cells.
(lanes 3–5 and 7–9). We could not stably express MN in (Figures 6Bb and 6Bc) while NEMO exhibited a diffuse
distribution (Figure 6Ba). We then analyzed the nuclearSVT-2C at the same level of expression as MSN (com-
pare lanes 3–5 and lanes 7–9). A stable SVT-2C clone translocation of NF-B in SVT-2C cells expressing MN
or MSN (Figure 6C). Strikingly, we observed in theseexpressing NEMO was used as control (lane 2). Indirect
immunofluorescence of stably transfected SVT-2C cells cells a constitutive nuclear translocation of NF-B (lanes
3–5 and 8–10) which was detected neither in the parentalconfirmed the membrane localization of MN and MSN
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cell line (lanes 1 and 6) nor in cells expressing NEMO ground. We took advantage of the fact that the p116
Jurkat cell line is deficient for the protein tyrosine kinase(lanes 2 and 7). We next examined the transcriptional
ZAP-70 and presents a severe defect in TCR-inducedactivity of these nuclear NF-B complexes by transfect-
signaling functions including NF-B activation (Herndoning a NF-B-dependent reporter construct into MN- (Fig-
et al., 2001; Williams et al., 1998). Because the tandemure 6D, left panel) and MSN-expressing cells (right
SH2 domains of ZAP-70 specifically bind to the phos-panel). We observed that MN and MSN could stimulate
phorylated ITAM motifs of TCR and CD3 (Hermistonthe activity of an NF-B luciferase reporter gene 30- to
et al., 2002), we constructed a chimera between these50-fold and 17-fold, respectively. These data suggest
SH2 domains and NEMO in order to allow induciblethat membrane recruitment of the IKK signalosome is
recruitment to the activated TCR. The SNEMO chimerasufficient to induce NF-B activation. We also observed
was indeed recruited to the immunological synapse fol-that this activation could be further increased by treat-
lowing TCR stimulation, and this recruitment could spe-ment with PMA/ionomycin but not with TNF (data not
cifically compensate the NF-B defect caused by theshown). Since in the latter case recruitment to the TNF
absence of ZAP-70. Moreover, in this context, the NF-Breceptor has been shown to be required for activation,
activation process was fast and persistent (Figure 3A,our results suggest that the membrane-targeted forms
bottom panel), perhaps because this mechanism of acti-of NEMO cannot be further recruited to the TNF receptor.
vation bypasses the requirement for other mediators
such as CARMA1, Bcl10, and MALT1. Since one of theDiscussion
possible functions of NEMO is to target the IB kinases
to specific locations following stimulation, it was con-The present study demonstrates that the signalosome
ceivable that recruitment of these kinases to the TCRcomplex is recruited to components of the T cell recep-
might be sufficient to activate NF-B. However, a chi-tor after its activation. Similar observations have shown
mera between the SH2 domains of ZAP-70 and IKK2that the signalosome is activated after being recruited
was not recruited to the TCR and thus could not activateto the TNF-R1 complex via the TNF receptor-associated
NF-B in response to TCR stimulation (data not shown).factor 2 (TRAF-2) (Li and Verma, 2002). However, this
This hypothesis was tested using several C- andmechanism of activation cannot be extended to all re-
N-terminally truncated NEMO molecules fused to ZAP-ceptors that signal through NF-B; for instance, in the
70 SH2 domains. A fusion protein including the 120case of IL-1-mediated signaling, the IL-1 receptor-asso-
N-terminal residues of NEMO constituted the minimalciated kinase (IRAK) is phosphorylated at the receptor
sequence required for NF-B activation. As this regioncomplex and then is thought to dissociate from the com-
represents the minimum domain required for the interac-plex to interact with TRAF-6 that in turn activates TAK1
tion between NEMO and the IKK kinases, it suggests(Li and Verma, 2002) which finally triggers the IB kinase
that the main role of NEMO is to target the kinases tocascade, leading to NF-B activation.
the TCR. Altogether, these data suggest that the require-We monitored the recruitment of endogenous NEMO
ment for ZAP-70 for NF-B nuclear translocation canto the TCR signaling complex, by immunoprecipitation
be bypassed by directly targeting the IKK complex to
and immunofluorescence. Altogether, these experi-
the TCR.
ments demonstrated that NEMO was rapidly recruited
A number of proteins have been implicated in NF-B
to the TCR (less than 5 min) and dissociated later (after
activation in T cells, and it would be interesting to deter-
30 min). By confocal microscopy, we observed an accu- mine if SNEMO can activate NF-B in their absence.
mulation of NEMO in the immunological synapse in both In particular, the analysis of PKC-deficient mice has
the peripheral and the central area, the latter colocaliz- revealed a selective T cell activation defect that involves
ing with the TCR cluster. Interestingly, the peripheral AP1 and NF-B (Sun et al., 2000). Moreover, transloca-
membrane protrusions where NEMO accumulated are tion of PKC to the rafts and association with the IB
areas of intense actin polymerization, which are en- kinases have been shown to be important for TCR-
riched in F-actin and in actin binding proteins (Roumier induced NF-B activation (Bi et al., 2001; Khoshnan et
et al., 2001). It is therefore tempting to speculate that al., 2000). Thus, PKC could play a role in activating the
the actin cytoskeleton may participate in the transloca- endogenous NEMO/IKK complex in rafts, and it would
tion of NEMO to the APC contact zone. We also ob- be interesting to evaluate its contribution in TCR-stimu-
served IKK coclustering with the TCR complex in the lated SNEMO-expressing cells as well as in MN-express-
immunological synapse (data not shown). Interestingly, ing cells. In fact, we have observed that the constitutive
it has been shown recently that key players that mediate NF-B activity found in MN- and MSN-expressing cells
TCR-induced NF-B activation, namely PKC, Bcl10, could be inhibited by Rottlerin, an inhibitor of atypical
and CARMA1, are also localized in the T cell-APC con- PKCs (of which PKC is the principal member in T cells),
tact area (Bi et al., 2001; Gaide et al., 2002). Moreover, suggesting that PKC is required for the activity of mem-
it has been suggested that CARMA1 may bridge PKC brane-targeted forms of NEMO.
and Bcl10 (Wang et al., 2002), and we can speculate Our system offers a powerful means of separating
that these proteins may participate in the recruitment distinct pathways leading to NF-B activation in re-
of the IKK complex to the immunological synapse. sponse to TCR stimulation. However, it is not clear how
We then asked whether the recruitment of the signalo- interaction of SNEMO with the TCR results in activation
some to the TCR was sufficient to activate NF-B. To of the IKK complex. One possibility is that the SNEMO/
address this question, we developed a system whereby IKK complex is activated by oligomerization. In support
the signalosome could be inducibly recruited to the re- of this hypothesis, Poyet and coworkers have demon-
strated that enforced oligomerization of NEMO, IKK,ceptor in an otherwise NF-B signaling-deficient back-
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acids 1–254 of ZAP-70, comprising the sequence encoding the SH2or IKK can induce IKK and NF-B activation (Poyet et
domains, was prepared by PCR. The PCR product was sequencedal., 2000). Experiments are in progress using the simpli-
and was ligated into HA-pcDNA-3-mNEMO at the BamHI and EcoRIfied systems involving SNEMO, MN, and MSN to ad-
sites or into HA-pcDNA-3-NRP at the BamHI site. To generate the
dress these points. pcDNA-3-MN plasmid, the membrane localization sequence of Lck
We also noticed that SNEMO was unable to induce (aa 1–12) was amplified by PCR and ligated into pcDNA-3-NEMO
at the BamHI and EcoRI sites. The pcDNA-3 MSN plasmid wasNF-B nuclear translocation in unstimulated cells de-
obtained by insertion of a double-stranded oligonucleotide codingspite its association with an important basal kinase ac-
for the membrane localization sequence of Src (aa 1–14) at thetivity (compare Figures 3A and 5C with Figures 3D and
BamH1 and EcoR1 sites of pcDNA-3-mNEMO plasmid. To generate5D). A high IKK kinase activity was also observed in MN-
HA-pcDNA-3-DN97, an Apo1-XbaI fragment of NEMO cDNA was
or MSN-expressing cells. We compared this activity to cloned into HA-pcDNA-3 vector digested with EcoRI and XbaI. Dele-
the one associated with wt NEMO or SNEMO in nonacti- tion of the C-terminal 292 amino acids of NEMO was obtained by
digestion of NEMO cDNA with StuI to generate HA-pcDNA-3-DC120.vated cells and found no difference (data not shown).
HA-pcDNA-3-DC255 was generated by digestion of NEMO cDNAThese results indicate that the mere activation of IB
with Bgl2 and encodes for NEMO with a deletion of the C-terminalkinases is not sufficient to activate NF-B and that the
157 amino acids. To generate HA-pcDNA-3-DC299, deletion of thekinase activity of IKKs is not increased when they are
C-terminal 117 amino acids of NEMO was obtained by digestion of
targeted to the membrane in the absence of specific NEMO cDNA with EcoRV.
signal. These results suggest that the critical event is
not the activation of the IKK complex but the targeting Synthetic Peptides
of this complex to the right location and in particular to Peptides corresponding to the first ITAM of the human TCR chain
(Grazioli et al., 1998) were synthesized as mono- (on Tyr 62) andthe TCR.
diphosphorylated (on Tyr51 and Tyr62) forms by F. Baleux (InstitutIn summary, we have designed a system that dissoci-
Pasteur, Paris).ates the NF-B cascade from the rest of T cell activation
and will allow us to separate the IKK-dependent from the
In Vitro Binding AssayIKK-independent events involved in NF-B activation in
In vitro translated 35S-SNEMO and 35S-SNRP (TNT Coupled Reticulo-response to TCR signaling.
cyte Lysate Systems, Promega) was added to the synthetic 2pY-
ITAM peptide (0.5M) containing a biotin molecule at the N terminus
Experimental Procedures in 1 Chris buffer (50 mM Tris [pH 8.0], 0.5% Nonidet P-40, 200
mM NaCl, and 0.1 mM EDTA) supplemented with 10 g/ml each of
Cell Culture and Reagents the protease inhibitors leupeptin, aprotinin, N-tosyl-L-phenylalanine
All cell lines were grown in Glutamax-containing RPMI (Life Technol- chloromethyl ketone (TPCK), N-p-tosyl-L-lysine chloromethyl ke-
ogies) supplemented with 10% FCS, 100 U/ml penicillin, 100 g/ml tone (TLCK), and phenylmethyl-sulfonyl fluoride (PMSF), as well as
streptomycin, and 50 M -mercaptoethanol. Wild-type Jurkat cells the phosphatase inhibitors sodium fluoride (100 mM) and sodium
(J77cl20) and Raji have been previously described (Niedergang et orthovanadate (2 mM), in the presence or absence of 50 M pY- or
al., 1997; San Jose´ et al., 2000). The Jurkat-derived ZAP-70-deficient 2pY-ITAM peptides. The mixtures were incubated at 4C for 1 hr
(p116) cell line was obtained from R.T. Abraham (Williams et al., with gentle rotation. Then, the protein complexes were collected
1998). P116 transfected back by wt ZAP cDNA (p116 ZAP wt) or a with streptavidin-agarose beads (Amersham Pharmacia). The beads
cDNA encoding for a ZAP mutated in its kinase domain (ZAP KD) were washed three times with 1 ml of 1 Chris buffer. Bound pro-
has been previously described (Di Bartolo et al., 2002; Mege et al., teins were subsequently eluted with sample buffer, boiled, and re-
1996). The Jurkat-derived NEMO-deficient (SVT-2C) cell line was a solved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
gift of S.C. Sun (Harhaj et al., 2000). The selection agent for ZAP wt phoresis.
and ZAP KD was puromycin (1 g/ml). P116 and SVT-2C derived
cells were maintained by continuous growing in the presence of 1
Cell Transfectionmg/ml G418.
Transfection of Jurkat-derived p116 and SVT-2C was carried out
by electroporation. Cells were pelleted and resuspended in HeBS
Antisera
2 (20 mM HEPES, 137 mM NaCl, 5 mM KCl, 0.8 mM NaHPO4,
The following Abs were used in this study: anti-NEMO monoclonal
2H2O [pH 7.05]) at 5  106 cells/0.5 ml. After addition of 30 g of
Ab (mAb) (clone 54, murine IgG1; Transduction Laboratories); poly-
linearized plasmid, the cells were electroporated in 4 mm cuvettes
clonal rabbit anti-NEMO Ab (Yamaoka et al., 1998); polyclonal rabbit
with a Biorad electroporator at 250 volts, 960 FD, and infinite
anti-NRP Ab (Schwamborn et al., 2000); polyclonal rabbit anti-IB
resistance. Monoclonal cell lines were isolated by limiting dilution.
Ab (Weil et al., 1997); anti-phospho-specific IB mAb (Biolabs);
anti-IKK1 mAb (PharMingen); anti-phospho-tyrosine mAb (4G10,
Preparation of Nuclear Extracts and Electrophoreticmurine IgG2B; UBI); anti-hemagglutinin mAbs 12CA5 (obtained from
Mobility Shift Assayan hybridoma) or HA.11 (Covance); anti-TCR mAb (Vit-3, murine
Nuclear extracts were prepared and analyzed as previously de-anti-IgM mAb; kindly provided by W. Knapp); anti-CD3 mAb (UCHT1,
scribed (Weil et al., 1999), using the probe 5-GATCTGGGGATTCCCmurine IgG1; Cymbus Biotechnology); rabbit anti-mouse IgG (Sigma);
CAT-3; 3-ACCCCTAAGGGGTACTAG-5.anti-CD28 mAb (CD28.2, murine IgG1; Immunotech); polyclonal rab-
bit anti-TCR chain Ab (kindly provided by O. Acuto); anti-TCR
chain mAb (6B10.2; Santa Cruz); fluorescein and Texas Red-coupled Activation, Immunoprecipitations, and Immunoblots
anti-Ig-specific (Southern Biotech); Alexa488-coupled anti-fluores- Treatment with anti-TCR, anti-CD3, and CD28
cein Ab (Molecular Probes). T cells were activated with anti-TCR mouse monoclonal antibody
(mAb) Vit-3 at 37C (1:100 dilution of ascite) for the indicated periods
of time. For luciferase assays, cells were incubated for 30 min atPlasmids and Constructs
Expression vectors for transfection into Jurkat-derived cells were 4C with 0.1 g/ml UCHT1 anti-CD3 mAb and then for 6 hr at 37C
with rabbit anti-mouse IgG (Sigma). In some cases, cells were alsoobtained by subcloning cDNAs into the mammalian expression vec-
tor pcDNA-3 (InVitrogen). Murine NEMO cDNA was ligated into the stimulated for the same period of time by the addition of 5 g/ml
anti-CD28 mAb.XhoI-XbaI restriction sites of HA-pcDNA-3 to create HA-pcDNA-3-
mNEMO or into the XbaI site of pcDNA-3 to create pcDNA-3- Treatment with Chemicals
Cells (5  106 ) were incubated for the indicated periods with 100mNEMO. NRP cDNA was ligated into the EcoRI site of HA-pcDNA-3
to create HA-pcDNA-3-NRP. The cDNA that encodes the amino ng/ml PMA (Sigma) and 1 M calcium ionophore (Sigma), or 100
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M N-Acetyl-Leu-Leu-Norleucinal (calpain inhibitor I, Sigma) as indi- Grazioli, L., Germain, V., Weiss, A., and Acuto, O. (1998). Anti-peptide
antibodies detect conformational changes of the inter-SH2 domaincated in the figure legends.
After induction, cells were lysed by adding 250 l of 1 Chris of ZAP-70 due to binding to the  chain and to intramolecular interac-
tions. J. Biol. Chem. 273, 8916–8921.buffer supplemented with protease and phosphatase inhibitors.
Specific polypeptides were then recovered by immunoprecipitation Harhaj, E.W., Good, L., Xiao, G., Uhlik, M., Cvijic, M.E., Rivera-Walsh,
and detected as descibed (Weil et al., 1997). I., and Sun, S.C. (2000). Somatic mutagenesis studies of NF-B
signaling in human T cells: evidence for an essential role of IKK in
Cell Transient Transfection, Activation, and Luciferase Assays NF-B activation by T-cell costimulatory signals and HTLV-I Tax
For transient transfection, 5 106 cells were transfected with 2 g protein. Oncogene 19, 1448–1456.
of either NFAT-luc reporter plasmid, Ig-cona-luc (made of three
Hermiston, M.L., Xu, Z., Majeti, R., and Weiss, A. (2002). Reciprocal
NF-B sites cloned upstream of the minimum conalbumin promoter)
regulation of lymphocytes activation by tyrosine kinases and phos-
or the control vector cona-luc by the DEAE dextran method. Trans-
phatases. J. Clin. Invest. 109, 9–14.
fected cells were cultured for 24 hr in RPMI. Then, cells were left
Herndon, T.M., Shan, X.C., Tsokos, G.C., and Wange, R.L. (2001).unstimulated or were stimulated with anti-CD3 and/or CD28 as indi-
ZAP-70 and SLP-76 regulate protein kinase C- and NF-B activa-cated above. Luciferase activity, determined in duplicate samples,
tion in response to engagement of CD3 and CD28. J. Immunol. 166,was expressed in arbitrary units. Fold induction was calculated as
5654–5664.the ratio of luciferase activity following transfection of Ig-cona-luc
divided by the activity in cells transfected with cona-luc alone. Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiqui-
tination: the control of NF-B activity. Annu. Rev. Immunol. 18,
Immune Complexes Kinase Assay 621–663.
Cells (5  106 ) were lysed with 1 Chris as described above. Five Khoshnan, A., Bae, D., Tindell, C.A., and Nel, A.E. (2000). The physi-
hundred micrograms of proteins from the lysates was then incu- cal association of protein kinase C- with a lipid raft-associated
bated with anti-NEMO, anti-ZAP(SH2), anti-HA, or anti-TCR anti- inhibitor of B factor kinase (IKK) complex plays a role in the activa-
body, and kinase assays were performed as previously described tion of the NF-B cascade by TCR and CD28. J. Immunol. 165,
(Yamaoka et al., 1998). 6933–6940.
Li, Q., and Verma, I.M. (2002). NF-B regulation in the immune sys-T Cell Activation Immunofluorescence and Confocal Microscopy
tem. Nature Rev. Immunol. 2, 725–734.Our procedure was carried out as previously described (Roumier et
May, M.J., D’Acquisto, F., Madge, L.A., Glockner, J., Pober, J.S.,al., 2001). Staining of fixed cells was performed with the apropriate
and Ghosh, S. (2000). Selective inhibition of NF-B activation by amAbs: anti-CD3 in PBS, 1 mg/ml BSA, followed by anti-NEMO in
peptide that blocks the interaction of NEMO with the IB kinasethe same solution supplemented with 0.1% Triton X-100. This was
complex. Science 289, 1550–1554.followed by fluorescein-coupled anti-IgG1 plus Texas Red-coupled
anti-IgG2a secondary Abs. Finally, fluorescein staining was en- Mege, D., Di Bartolo, V., Germain, V., Tuosto, L., Michel, F., and
hanced by Alexa488-coupled anti-fluorescein Abs. Microscopy Acuto, O. (1996). Mutation of tyrosines 492/493 in the kinase domain
analysis was performed in a Zeiss LSM-510 confocal microscope. of ZAP-70 affects multiple T-cell receptor signaling pathways. J.
Z series of optical sections were performed at 0.5 m increments. Biol. Chem. 271, 32644–32652.
Green and red fluorescences were collected separately. Image anal-
Monks, C.R., Freiberg, B.A., Kupfer, H., Sciaky, N., and Kupfer, A.ysis was carried out using LSM-510 software.
(1998). Three-dimensional segregation of supramolecular activation
clusters in T cells. Nature 395, 82–86.
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